US4542025A
(en)
|
1982-07-29 |
1985-09-17 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
US5573933A
(en)
|
1987-04-14 |
1996-11-12 |
Luminis Pty, Ltd. |
Transgenic pigs
|
US5532220A
(en)
|
1987-08-31 |
1996-07-02 |
The Regents Of The University Of California |
Genetic mechanisms of tumor suppression
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
US5240846A
(en)
|
1989-08-22 |
1993-08-31 |
The Regents Of The University Of Michigan |
Gene therapy vector for cystic fibrosis
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
AU660629B2
(en)
|
1990-10-01 |
1995-07-06 |
University Of Connecticut, The |
Targeting viruses and cells for selective internalization by cells
|
US5831141A
(en)
|
1991-01-11 |
1998-11-03 |
United States Of America As Represented By The Department Of Health And Human Services |
Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
|
JPH06510524A
(ja)
|
1991-05-14 |
1994-11-24 |
ユニバーシティ オブ コネチカット |
免疫原性タンパク質をコードする遺伝子の標的への配達
|
DE69231385T2
(de)
|
1991-06-05 |
2001-04-12 |
Univ Connecticut Storrs |
Zielgerichtete freisetzung von genen, die sekretorische proteine kodieren
|
WO1993014188A1
(en)
|
1992-01-17 |
1993-07-22 |
The Regents Of The University Of Michigan |
Targeted virus
|
US5338843A
(en)
|
1992-01-30 |
1994-08-16 |
Becton, Dickinson And Company |
Fluorogenic and chromogenic β-lactamase substrates
|
AU3940293A
(en)
|
1992-04-03 |
1993-11-08 |
Alexander T. YOUNG |
Gene therapy using targeted viral vectors
|
US5565324A
(en)
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
WO1994008598A1
(en)
|
1992-10-09 |
1994-04-28 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
EP0905253A3
(en)
|
1992-12-03 |
2000-11-02 |
Genzyme Corporation |
Adenoviral vector deleted of all E4-ORF except ORF6
|
WO1994024301A1
(en)
|
1993-04-21 |
1994-10-27 |
The University Of Edinburgh |
Expression of heterologous genes according to a targeted expression profile
|
WO1994029469A2
(en)
|
1993-06-07 |
1994-12-22 |
Vical Incorporated |
Plasmids suitable for gene therapy
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
US5942496A
(en)
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
US5962427A
(en)
|
1994-02-18 |
1999-10-05 |
The Regent Of The University Of Michigan |
In vivo gene transfer methods for wound healing
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
US5675060A
(en)
|
1994-05-19 |
1997-10-07 |
Institut National De La Sante Et De La Recherche Medicale |
Transgenic arthritic mice expressing a T-cell receptor transgene
|
US5850001A
(en)
|
1994-06-06 |
1998-12-15 |
Universite De Montreal |
Transgenic mouse for the neuronal expression of HIV gp160
|
US5907030A
(en)
|
1995-01-25 |
1999-05-25 |
University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US5669907A
(en)
|
1995-02-10 |
1997-09-23 |
Valleylab Inc. |
Plasma enhanced bipolar electrosurgical system
|
US5814300A
(en)
|
1995-03-03 |
1998-09-29 |
Cephalon, Inc. |
Gene-targeted non-human mammals deficient in the SOD-1 gene
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
US5751629A
(en)
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
BR9610058A
(pt)
|
1995-07-28 |
1999-07-27 |
Marie Curie Cancer Care |
Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
|
FR2739621B1
(fr)
|
1995-10-05 |
1997-12-05 |
Centre Nat Rech Scient |
Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
|
EP0774464B1
(en)
|
1995-10-17 |
2004-07-28 |
Combichem, Inc. |
A template for solution phase synthesis of combinatorial libraries
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
DE69625620T2
(de)
|
1996-08-23 |
2003-08-21 |
Sederma Sa |
Synthetische peptide und ihre verwendung in kosmetischen oder dermopharmazeutischen zusammensetzungen
|
CA2468374C
(en)
|
1996-08-30 |
2010-12-21 |
Novo-Nordisk A/S |
Glp-1 derivatives
|
US5928888A
(en)
|
1996-09-26 |
1999-07-27 |
Aurora Biosciences Corporation |
Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
|
US5906923A
(en)
|
1996-10-02 |
1999-05-25 |
Incyte Pharmaceuticals, Inc. |
ATPase inhibitor
|
US5798035A
(en)
|
1996-10-03 |
1998-08-25 |
Pharmacopeia, Inc. |
High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
|
GB9714680D0
(en)
|
1997-07-11 |
1997-09-17 |
Medical Res Council |
Recombinant production of proteins
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
AU2610699A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
FR2783169B1
(fr)
|
1998-09-15 |
2001-11-02 |
Sederma Sa |
Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
|
US6492326B1
(en)
|
1999-04-19 |
2002-12-10 |
The Procter & Gamble Company |
Skin care compositions containing combination of skin care actives
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20030026781A1
(en)
|
1999-11-10 |
2003-02-06 |
Mitokor |
Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
|
AU1759901A
(en)
*
|
1999-11-10 |
2001-06-06 |
Mitokor |
Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
|
US20040072739A1
(en)
|
1999-11-10 |
2004-04-15 |
Anderson Christen M. |
Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
|
SE0002232D0
(sv)
|
2000-06-15 |
2000-06-15 |
Vulpes Ltd |
Antioxidant
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
US7049286B2
(en)
|
2001-08-30 |
2006-05-23 |
Diatos, S.A. |
Insulin conjugates and methods of use thereof
|
FR2830195B1
(fr)
|
2001-10-03 |
2004-10-22 |
Sederma Sa |
Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
|
ATE510852T1
(de)
|
2001-10-30 |
2011-06-15 |
Dsm Ip Assets Bv |
Dermopharmazeutisch und kosmetisch wirksame oligopeptide
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
FR2836042B1
(fr)
|
2002-02-15 |
2004-04-02 |
Sederma Sa |
Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
|
JP2005527209A
(ja)
|
2002-04-22 |
2005-09-15 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
疼痛管理のためのプロテインキナーゼCγのペプチドインヒビター
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
KR101116528B1
(ko)
|
2003-05-08 |
2012-02-28 |
디에스엠 아이피 어셋츠 비.브이. |
피부구조를 향상시키는 트리펩타이드 및 그 유도체의 미용용도
|
US7208595B2
(en)
|
2003-07-25 |
2007-04-24 |
The Ohio State University Research Foundation |
Peptide deformylase inhibitors as novel antibiotics
|
US9695251B2
(en)
|
2003-10-31 |
2017-07-04 |
The Regents Of The University Of California |
Activatable cell penetrating peptides with quenched fluorophores
|
WO2011008992A2
(en)
|
2009-07-15 |
2011-01-20 |
The Regents Of The University Of California |
Peptides whose uptake in cells is controllable
|
US7985401B2
(en)
|
2003-10-31 |
2011-07-26 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
US7431915B2
(en)
|
2003-10-31 |
2008-10-07 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
AU2003296248A1
(en)
|
2003-11-17 |
2005-06-08 |
Sederma |
Compositions containing mixtures of tetrapeptides and tripeptides
|
US8092788B2
(en)
|
2004-03-03 |
2012-01-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
EP1861112A4
(en)
|
2005-03-03 |
2009-07-22 |
Revance Therapeutics Inc |
COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
US7659252B2
(en)
|
2005-09-15 |
2010-02-09 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
US8404648B2
(en)
|
2006-02-16 |
2013-03-26 |
Sederma |
Polypeptides KXK and their use
|
ATE495197T1
(de)
|
2006-03-20 |
2011-01-15 |
Cepep Iii Ab |
Chimäre konstrukte zwischen auf krebs zielenden peptiden und zellpenetrierenden peptiden gekoppelt an antikrebsmittel und/oder diagnostische mittel
|
US8410045B2
(en)
|
2006-03-30 |
2013-04-02 |
Drais Pharmaceuticals, Inc. |
Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
|
MX2009007070A
(es)
|
2006-12-29 |
2009-07-10 |
Revance Therapeutics Inc |
Moleculas de transporte que utilizan los polipeptidos hiv-tat de secuencia inversa.
|
WO2008089491A2
(en)
|
2007-01-19 |
2008-07-24 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
KR20100074177A
(ko)
|
2007-09-10 |
2010-07-01 |
유니버시티 오브 매사추세츠 |
미토콘드리아-표적화된 항-종양 물질
|
EP2474613B2
(en)
|
2008-02-05 |
2022-02-16 |
BicycleRD Limited |
Methods and compositions
|
ES2330291B1
(es)
|
2008-02-29 |
2010-10-18 |
Lipotec Sa |
Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
|
WO2009127060A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
WO2010039088A1
(en)
|
2008-09-16 |
2010-04-08 |
Kariem Ahmed |
Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
|
WO2010111533A2
(en)
|
2009-03-25 |
2010-09-30 |
Kai Pharmaceuticals, Inc. |
Transdermal delivery of pkc modulatory peptides through microporated skin
|
US8946166B2
(en)
|
2009-07-24 |
2015-02-03 |
Lipotec, S.A. |
Peptide-based compounds and compositions which inhibit muscle contraction
|
JP2013516471A
(ja)
|
2010-01-06 |
2013-05-13 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
薬物の脂肪酸誘導体および類似体
|
CN103097397B
(zh)
|
2010-05-30 |
2015-11-25 |
多伦多大学管理委员会 |
作为抗癌化合物载体的线粒体穿透肽
|
US20130078295A1
(en)
|
2010-06-09 |
2013-03-28 |
Lipotec S.A. |
Skin antiaging treatment
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
US9408542B1
(en)
|
2010-07-22 |
2016-08-09 |
Masimo Corporation |
Non-invasive blood pressure measurement system
|
CN104531671A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
WO2012064429A2
(en)
|
2010-11-09 |
2012-05-18 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use thereof
|
WO2012115980A1
(en)
|
2011-02-22 |
2012-08-30 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (aav) vectors
|
ES2397890B1
(es)
|
2011-03-25 |
2014-02-07 |
Lipotec, S.A. |
Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
|
CN114262690A
(zh)
|
2011-04-15 |
2022-04-01 |
吉恩勒克斯公司 |
减毒的痘苗病毒的克隆毒株及其使用方法
|
TWI497333B
(zh)
|
2011-06-14 |
2015-08-21 |
Giant Mfg Co Ltd |
自行車適配產生方法、自行車適配系統與電腦程式產品
|
US9333152B2
(en)
|
2011-11-04 |
2016-05-10 |
Lipotec, S.A. |
Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
|
AU2012347931A1
(en)
|
2011-12-09 |
2014-07-03 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9104666B2
(en)
|
2012-09-04 |
2015-08-11 |
Oracle International Corporation |
Controlling access to a large number of electronic resources
|
FR2998570B1
(fr)
|
2012-11-26 |
2016-12-02 |
Sederma Sa |
Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
|
WO2014120837A2
(en)
|
2013-01-29 |
2014-08-07 |
The Regents Of The University Of California |
Pretargeted activatable cell penetrating peptide with intracellulary releaseable prodrug
|
US20140227174A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use therefor
|
WO2014123543A2
(en)
|
2013-02-11 |
2014-08-14 |
Convoy Therapeutics |
Skin permeating and cell entering (space) peptides and methods of use therefor
|
US20140234275A1
(en)
|
2013-02-15 |
2014-08-21 |
Jason Williams |
Method for treating als via the increased production of factor h
|
US10577303B1
(en)
|
2013-03-14 |
2020-03-03 |
Wisconsin Alumni Research Foundation |
Reagents and methods for esterification
|
US10287331B2
(en)
|
2013-04-15 |
2019-05-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Mitochondrial proteins constructs and uses thereof
|
EP2792684A1
(en)
|
2013-04-15 |
2014-10-22 |
Lipotec, S.A. |
Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
|
WO2014190257A2
(en)
|
2013-05-23 |
2014-11-27 |
Ohio State Innovation Foundation |
Chemical synthesis and screening of bicyclic peptide libraries
|
CA2916492A1
(en)
|
2013-06-27 |
2014-12-31 |
Stealth Biotherapeutics Corp |
Peptide therapeutics and methods for using same
|
GB2516045A
(en)
|
2013-07-09 |
2015-01-14 |
Neuro Bio Ltd |
Neurodegenerative disorders
|
WO2015023649A2
(en)
|
2013-08-12 |
2015-02-19 |
3M Innovative Properties Company |
Peptides for enhancing transdermal delivery
|
WO2015179434A1
(en)
|
2014-05-20 |
2015-11-26 |
Ohio State Innovation Foundation |
Small molecule ras inhibitors
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
PT3149025T
(pt)
|
2014-05-21 |
2019-08-01 |
Entrada Therapeutics Inc |
Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
|
FR3021319B1
(fr)
|
2014-05-22 |
2018-08-31 |
Sederma |
Peptides, compositions les comprenant et utilisations notamment cosmetiques
|
US20170258930A1
(en)
|
2014-08-27 |
2017-09-14 |
The Regents Of The University Of California |
Skin penetrating peptides (spps) and methods of use therefor
|
US10258695B2
(en)
|
2014-09-04 |
2019-04-16 |
Wisconsin Alumni Research Foundation |
Protein derivatization to endow cell penetration
|
US10385380B2
(en)
|
2014-10-02 |
2019-08-20 |
The Regents Of The University Of California |
Personalized protease assay to measure protease activity in neoplasms
|
CA2965754C
(en)
|
2014-10-29 |
2024-01-02 |
Bicycle Therapeutics Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
GB2539161A
(en)
|
2014-11-26 |
2016-12-14 |
Neuro-Bio Ltd |
Neurodegenerative disorders
|
FR3029782B1
(fr)
|
2014-12-16 |
2019-06-07 |
Sederma |
Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
|
EP3936141A3
(en)
|
2015-01-23 |
2022-03-23 |
Erasmus University Rotterdam Medical Center |
Anti-senescence compounds and uses thereof
|
US9790483B2
(en)
|
2015-04-09 |
2017-10-17 |
Wisconsin Alumni Research Foundation |
Reagents and methods for esterification
|
US10596259B2
(en)
|
2015-05-20 |
2020-03-24 |
The Regents Of The University Of California |
Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
|
WO2017048812A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Skin-penetrating peptides and compositions and methods of use thereof
|
LT3350157T
(lt)
|
2015-09-17 |
2022-02-25 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
MD3718565T2
(ro)
|
2015-10-22 |
2022-09-30 |
Modernatx Inc |
Vaccinuri împotriva virusului respirator
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
TWI781963B
(zh)
|
2016-11-09 |
2022-11-01 |
俄亥俄州立創新基金會 |
含二硫化物細胞穿透肽及其製造與使用方法
|
US20190309020A1
(en)
|
2016-11-22 |
2019-10-10 |
Ohio State Innovation Foundation |
Cell-penetrating peptide sequences
|
US10913773B2
(en)
|
2016-11-22 |
2021-02-09 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
|
US11352394B2
(en)
|
2016-11-22 |
2022-06-07 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
US10624968B2
(en)
|
2017-01-06 |
2020-04-21 |
Bicyclerd Limited |
Compounds for treating cancer
|
US20220273664A1
(en)
|
2017-06-23 |
2022-09-01 |
The Governing Council Of The University Of Toronto |
Mitochondrial Targeted Releasable Linker
|
RU2020105742A
(ru)
|
2017-07-13 |
2021-08-13 |
Майкл Девид ФОРРЕСТ |
Терапевтические модуляторы обратного режима атф-синтазы
|
US11339192B2
(en)
|
2017-10-04 |
2022-05-24 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
US11576946B2
(en)
|
2018-01-29 |
2023-02-14 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-NFAT interaction
|
EP3746105A4
(en)
|
2018-01-29 |
2022-05-18 |
Ohio State Innovation Foundation |
CAL-PDZ BINDING DOMAIN CYCLIC PEPTIDYL INHIBITORS
|
FR3077202B1
(fr)
|
2018-02-01 |
2020-01-10 |
Sederma |
Utilisation de cyclopeptides en cosmetique
|
WO2019199841A1
(en)
|
2018-04-09 |
2019-10-17 |
Cure Ahc, Inc. |
Aav-mediated delivery of atp1a3 genes to central nervous system
|
CA3050553A1
(en)
|
2019-07-25 |
2021-01-25 |
Michael D. Forrest |
Therapeutic modifiers of the reverse mode of atp synthase
|